Answers are grounded in this paper and cite their sources.
Progressive vision loss in adults is rising steadily, worldwide, alongside increased longevity and mounting chronic and metabolic disorders, such as age-related macular degeneration and diabetic retinopathy. Contemporary cell replacement therapy offers therapeutic promise for its potential to replace dystrophic and/or apoptotic photoreceptors with stem cell-derived neurons. However, the integration of transplanted retinal donor cells remains rare and difficult to manipulate, as low numbers of donor cells migrate appropriately within the damaged retinal host. The current study applied electric field stimulation to induce donor cell migration using alternating currents (ACs) applied in modern ophthalmic therapies for retinal disease. We extended our 3D electrotaxis assay, the BioEye, to apply minimal bursts of electric field stimulation across retinal facsimiles composed of established, biomimetic hydrogels. Tests used AC fields with biphasic and monophasic parameters of different waveforms. Results illustrate that positive, monophasic AC fields of triangle and square waveforms stimulated over 5-fold the number of motile cells than that of control (no EF), while similar biphasic fields produced over 2-fold the number of motile cells than control with consistent high cell viability in all tests. These findings suggest exciting and unexplored opportunities for EF-based strategies to help promote donor cell integration in retinal cell replacement therapy.
No takes yet. Share an insight, caveat, or question.
Devecka et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: